Benzodiazepines: Difference between revisions
Feedback

From WikiLectures

mNo edit summary
mNo edit summary
Line 77: Line 77:


===Hypnotics===
===Hypnotics===
Represent contemporary '''drugs of choice''' in the therapy of insomnia. They belong thethe second generation of hypnotics.
BZs represent contemporary '''drugs of choice''' in the therapy of insomnia. They belong to the second generation of hypnotics.


Tato hypnotika potlačují REM spánek lehce nebo středně silně. [[Játra|Jaterní]] mikrosomální enzymy pod jejich dlouhodobějším vlivem nepodléhají indukci. U těchto léků je rozpětí mezi toxickými a terapeutickými dávkami (tj. ''farmakoterapeutické okno'') široké.   
These hypnotics suppress the REM phase with light or moderate effect. Their long-term use does not cause an increase in hepatic microsomal enzymes. There is a significant difference between toxic and therapeutic doses.   


Při opakovaném podání je riziko lékové závislosti menší než u barbiturátů. Abstinenční syndrom probíhá pod obrazem nespavosti, tremoru, v těžších případech jako epileptický záchvat, halucinace a delirium. Závažnost abstinečních příznaků závisí na posledních dávkách hypnotika (čím vyšší dávka, tím nebezpečnější projevy abstinenčního syndromu), na hodnotě biologického poločasu léku (čím kratší poločas, tím větší nebezpečí vyvolání abstinenčního syndromu).  
The risk of dependence caused by prolonged use is lower than in barbiturates. Withdrawal syndrome manifests by insomnia, tremor, in more severe cases as an epileptic seizure, hallucinations, and delirium. Severeness of withdrawal symptoms depends on the latest doses of hypnotics (the higher the dose, the more severe are the symptoms of withdrawal syndrome), the biological half-life of the drug (the lower the half-life, the higher is the risk of causing withdrawal syndrome).  


Benzodiazepiny mají ''specifického antagonistu na BZ receptorech'' '''''flumazenil'''''. S jeho využitím lze rychle zrušit efekt benzodiazepinů (nikoliv barbiturátů ani [[alkohol]]u).
Benzodiazepines have ''a'' ''specific antagonist on BZ receptors'' - '''''flumazenil'''''. Its use can quickly counter the effect of benzodiazepines (but not barbiturates nor alcohol).
{{Podrobnosti|Intoxikace benzodiazepiny}}


Benzodiazepiny jsou synergisty všech léků tlumících CNS. Mají nepříznivé vlivy na paměťové a jiné kognitivní funkce (koncentrace pozornosti a úsudku, schopnost učení), což se může projevit jako amnezie, poruchy kontinuity vědomí, a to zejména u starších lidí. Nehodí se u lidí, u nichž se vyžaduje zvýšená pozornost a reaktivita (řízení motorového vozidla, obsluha strojů). Zesilují také účinky alkoholu a opačně alkohol inhibuje metabolizmus dlouhodobě působících benzodiazepinů (např. inhibice se projevuje ještě 10 hod po požití poslední dávky diazepamu).  
Benzodiazepines are synergists of all drugs that cause the depression of the CNS. They have adverse effects on memory and other cognitive functions (concentration and judgment, learning capability), which may manifest as amnesia, the disruption of memory continuity, especially among elderly people. They are not well suited for people that require high alertness and fast reactions (driving, operating heavy machinery). They increase the effects of alcohol and inversely, the alcohol inhibits the metabolism of long-duration benzodiazepines (e.g. the inhibition lasts for 10 hours after taking the last dose of diazepine).  


Mezi hypnotiky existuje ''zkřížená tolerance'' a lze sem přiřadit i alkohol. Tím je vysvětleno, proč vlivem standardních dávek hypnotik nelze navodit dostatečný efekt u jedinců s anamnézou recentního nadměrného používání těchto hypnotik nebo alkoholu.  
Hypnotics, including alcohol, are affected by ''cross-tolerance.'' This explains why it is impossible to cause sufficient effect in patients with a history of alcohol or hypnotics abuse.  


Léky obou skupin anxiolytik procházejí rychle placentární bariérou. Plodem jsou metabolizována pomaleji. [[Teratogenní]] efekt nebyl prokázán, ale někteří autoři popisují častější výskyt [[rozštěpové vady|rozštěpů]] rtů, patra, nižší porodní hmotnost a délku u plodů matek, kde byly tyto léky používány v 1. trimestru [[těhotenství]]. Jsou-li podávána v posledním trimestru, pak mohou vést k toxickým projevům u novorozence (k letargii, hypotonii, hypotermii – tzv. "floppy infant") nebo k [[abstinenční syndrom|abstinenčnímu syndromu]] (třes, tachypnoe, křečové projevy aj). Proto se doporučuje vysadit [[anxiolytika]] již měsíc před porodem. Benzodiazepinová anxiolytika přecházejí do mateřského mléka a mohou vést k nadměrné sedaci kojence. Proto matky užívající anxiolytika se středním až dlouhým t<sub>1/2</sub> by neměly kojit.
Drugs of both categories of anxiolytics quickly pass through the placental barrier. The fetus doesn't metabolize them as quickly as an adult. The teratogenic effect hasn't been proved, but some sources describe the increased incidence of cleft lip and palate and low birth weight and length in feti of mothers that used these drugs in the 1st trimester of pregnancy. If they are used in the 3rd trimester, they may lead to toxic manifestations in the newborn (lethargy, hypotony, hypothermia - so-called "floppy infant") or withdrawal symptoms (tremor, tachypnoea, spasticity, etc.). It is therefore recommended to stop using anxiolytics one month before the childbirth. Benzodiazepine anxiolytics pass to the mother's milk and may lead to sedation of the infant. Because of this, mothers using anxiolytics with medium to long half-life shouldn't breastfeed.  


#Benzodiazepiny '''se silným účinkem hypnotickým''' a slabým anxiolytickým  
#Benzodiazepiny '''se silným účinkem hypnotickým''' a slabým anxiolytickým  
Line 104: Line 103:


===Sedatives===
===Sedatives===
'''Sedativa''' jsou látky vedoucí k uklidnění, útlumu duševní i motorické aktivity, k ospalosti a únavě. Používají se k uklidnění nemocných léčených např. pro [[hypertenze|hypertenzi]], vegetativní [[dystonie|dystonii]] (nadměrné pocení, palpitace, návaly horka) aj. Jejich toxicita je nízká.
'''Sedatives''' are substances that cause sedation, a decrease of psychic and motoric activity, drowsiness, and fatigue. They are used to sedate patients treated with hypertension, vegetative dystonia (increased perspiration, palpitation, hot flashes), and others. Their toxicity is low.


===Antiepileptics (anticonvulsives)===
===Antiepileptics (anticonvulsives)===
BZD patří mezi antiepileptika 2. generace; patří sem např.: klonazepam, diazepam, lorazepam (absence, status epilepticus).
BZD belongs to 2nd generation antiepileptics. Others in this category are clonazepam, diazepam, lorazepam (status epilepticus, absence seizure)


*[[Klasifikace epileptických záchvatů|status epilepticus]] vyžaduje i.v. diazepam, lorazepam, midazolam<ref name="Seidel">{{Citace
*status epilepticus requires i. v. diazepam, lorazepam, midazolam
|typ = kniha
*'''mechanism of the effect of BZD antiepileptics''': ''potentiation of GABA'S effect'' (also valproate, barbiturate, vigabatrin, tiagabine)<br />
|příjmení1 = SEIDL
|jméno1 = Zdeněk
|příjmení2 = OBENBERGER
|jméno2 = Jiří
|kolektiv = ne
|titul = Neurologie pro studium i praxi
|vydání = 2
|místo = Praha
|vydavatel = Grada Publishing
|rok = 2004
|isbn = 80-247-0623-7
}}</ref>


*'''mechanismus účinku BZD antiepileptik:''' ''potenciace účinku [[GABA]]'' (také valproát, barbituráty, vigabatrin, tiagabin) <ref name="Hynie">{{Citace
===Muscle relaxants===
|typ = kniha
Benzodiazepines are acting as central muscle relaxants.
|příjmení1 = Hynie
|jméno1 = Sixtus
|titul = Farmakologie v kostce
|vydání = 2
|místo = Praha
|vydavatel = Triton
|rok = 2001
|isbn = 80-7254-181-1
}}</ref>


Muscle relaxants:


===Muscle relaxants===
*Affect spasticity (myotonolytics)
Benzodiazepiny patří mezi '''centrální''' myorelaxancia. Myorelaxancia:
*Suppress mono- and polysynaptic reflexes in the brain and spinal cord
*Takes effect in the GABA area, decreasing the generation of action potentials in the neurons


*Ovlivňují spasticitu (myotonolytika),
*Tlumí mono- a polysynaptické reflexy v mozku a míše,
*Působí v oblasti [[GABA]], snižují vznik [[akční potenciál (fyziologie)|akčních potenciálů]] na nervových vláknech.


Benzodiazepiny:
Benzodiazepines:


*Napomáhá účinku GABA, otevírají [[iontové kanály|Cl kanály]],
*Stimulate GABA's effect and open Cl channels
*Relaxují svaly (myorelaxanc) i psychiku ([[anxiolytika|anxiolytikum]]).
*Relax the muscles (muscle relaxant) and psyche (anxiolytic)


Do centrálních myorelaxancií patří kromě benzodiazepinů také baklofen.
Another example of central muscle relaxants is baclofen.


==Links==
==Links==
===Related atricles===
===Related atricles===


*[[Benzodiazepiny (pediatrie)]]
*[[Antiepileptika|Antiepileptics]]
*[[intoxikace benzodiazepiny]]
*[[Anxiolytika|Anxiolytics]]
*[[Antiepileptika]]
*[[Hypnotika|Hypnotics]]
*[[Anxiolytika]]
*[[Hypnotika]]


===References===
===References===
<references />
===Used literature===
===Used literature===
*{{Citace
| typ = kniha
| isbn = 80-7254-181-1
| příjmení1 = Hynie
| jméno1 = Sixtus
| titul = Farmakologie v kostce
| vydání = 2
| místo = Praha
| vydavatel = Triton
| rok = 2001
| rozsah = 520
}}
*{{Citace
| typ = kniha
| isbn = 80-7262-168-8
| příjmení1 = Lincová
| jméno1 = Dagmar
| kolektiv = ano
| titul = Základní a aplikovaná farmakologie
| vydání = 1
| vydavatel = GALÉN
| rok = 2002
| rozsah = 601
}}
</noinclude>
</noinclude>


[[Kategorie:Farmakologie]]
<br />
[[Kategorie:Neurologie]]
[[Kategorie:Adiktologie]]
[[Kategorie:Psychiatrie]]
[[Kategorie:Vnitřní lékařství]]

Revision as of 03:13, 19 November 2020

5mg/ml Diazepam for intravenous use

Benzodiazepines (BZD, BDZ, BZs) are highly effective drugs with anxiolytic, sedative, anticonvulsant, muscle relaxant, hypnotic, and amnesic actions. They are among the most commonly prescribed classes of psychoactive drugs, primarily because of their fast and highly specific effect. However, they are also quite often overprescribed and abused.

Indications

  • Anxiety disorders and phobias, stress, mixed anxiety-depression disorders;
  • acute agitation - agression of various nature (e.g. mania, schiophrenia, somatics illness, etc.);
  • withdrawal symptoms and detoxification in alcohol and barbiturate dependency;
  • sleeping disorders, insomnia;
  • epilepsy, status epilepticus;
  • akathisia, muscle spasms, and spasticity
The skeletal structure of diazepam

Contraindications

  • Oversensitivity to benzodiazepines;
  • myasthenia gravis (except tofisopam);
  • acute intoxication by alcohol, hypnotics, psychoactive drugs, analgetics, and other substances with depressive effect on the CNS;
  • gravidity and lactation,
  • alcohol or substance abuse
  • sleep apnea, sensory and cerebellar ataxia, severe liver or kidney disease, chronic respiratory failure

Common adverse effects

  • Daytime fatigue and somnolence, decreased alertness - increased risk of a traffic accident!;
  • ataxia, confusion, dizziness, hypotension, risk of falling;
  • respiratory insufficiency (particularly when combined with CNS depressants);
  • paradoxical reactions, such as anger, irritabililty, aggression, euphoria, insomnia;
  • amotivational syndrome - apathy and passivity.

Addction and withdrawal

Long-term and regular use of high doses of benzodiazepines leads to increased tolerance and dependence. Since the therapy of BZD addiction is difficult and time-costly, prevention is the key in this regard. BZs should only be used when necessary and when no safer alternatives are available. The total period of usage should be limited to the shortest time possible (most commonly 4-6 weeks). Predispositions for benzodiazepine dependence are chronic somatic diseases (particularly chronic pains), personality disorders, alcohol or other addictions, and chronic sleep disorders.

Abrupt dose reduction or discontinuation may lead to benzodiazepine withdrawal syndrome, followed by rebound phenomena - anxiety, insomnia, agitation. The most common symptoms of the withdrawal are irritability, increased perspiration, nausea and emesis, tremor, headache, muscle tension, dysphoria, insomnia, dysphoria, insomnia, tension, and palpitation. Severe withdrawal symptoms include delirium, confusion, epilepsy seizures, psychotic states including hallucinations or paranoia. To prevent withdrawal syndrome, it is most important to decrease the BZD doses gradually over several weeks. If the withdrawal syndrome manifests, low doses of BZD are reintroduced to ease the symptoms. The use of antiepileptics (e. g. carbamazepine) is also recommended in such cases.

Overdose

Overdose clinically manifests by somnolence, slurred speech, muscle hypotonia, and respiratory depression with possible myocloni or coma followed by decreased blood pressure and low pulse. It is treated by the antagonist of benzodiazepine receptors - flumazenil.

List of commonly used benzodiazepines

Side effects of alprazolam
  • Alprazolam (Xanax) – has a highly specific anxiolytic effect, and is used for the treatment of anxiety disorders, panic disorders, and also for short-term therapy of neurotic-induced insomnia.
  • Diazepam (Valium) – a sedative with a long-lasting effect, has strong anxiolytics effects but has also significant hypnotic, anticonvulsive, and muscle relaxative effects. Has a very fast onset of effects. Diazepam is used to treat agitation with psychomotor restlessness, anxiety, status epilepticus, and spasticity. Prolonged use may lead to dependence. Dosage differs among patients, ranging from 2 to 50 mg, with maximum doses being used before sleep.
  • Bromazepam – similar effect as diazepam, also has an antidepressive effect. Used for pre-surgery sedation.
  • Clonazepam – besides the anxiolytic use has an anticonvulsive effect and is indicated for spasticity and epilepsy (including absence seizures). It is also used to treat withdrawal symptoms of alcohol dependence. Compared to alprazolam and bromazepam, clonazepam has increased sedative and hypnotic effects.
  • Oxazepam – has a shorter and weaker effect than diazepam but with fewer side effects, and is therefore foten used in ambulatory care.
  • Tofisopam – has no muscle relaxant effect, and can be used in patients with myopathy - including myasthenia gravis.
  • Nitrazepam – long-lasting and effective hypnotics used to prevent nocturnal or early awakening. Has muscle relaxant effect (suitable for insomnia caused by pain from increased muscle tonus), does not have active metabolites
  • Flunitrazepam – hypnotic with medium-term effect used for troubles with falling asleep (mostly historically, is no longer used becase of side effect and potential for abuse)

Benzodiazepines sorted by effects

Anxiolytics

Drugs with prevalent anxiolytic effects are used in this indication.

List of benzodiazepine anxiolytics by elimination half-life (t 0,5; brackets contain usual daily doses used for anxiolytic effect)

  • long t1/2 (> 24 hours):
    • diazepam (5–40mg), medazepam (10–60 mg), clobazam (20–30 mg), clonazepam (0,5–4 mg), chlordiazepoxid (10–50 mg),
    • are biotransformed by oxidative reactions in the liver
    • their elimination is prolonged in patients with decreased liver function and elderly people
  • medium t1/2 (12–24 hours)
    • alprazolam (0,5–4 mg) bromazepam (3–15 mg)
  • short t1/2 (<12 hours):
    • oxazepam (30–90 mg), tofizopam (50–300 mg), lorazepam (2–6 mg)
    • are metabolized by conjugation with glucuronides with significantly lower dependence on liver function

Hypnotics

BZs represent contemporary drugs of choice in the therapy of insomnia. They belong to the second generation of hypnotics.

These hypnotics suppress the REM phase with light or moderate effect. Their long-term use does not cause an increase in hepatic microsomal enzymes. There is a significant difference between toxic and therapeutic doses.

The risk of dependence caused by prolonged use is lower than in barbiturates. Withdrawal syndrome manifests by insomnia, tremor, in more severe cases as an epileptic seizure, hallucinations, and delirium. Severeness of withdrawal symptoms depends on the latest doses of hypnotics (the higher the dose, the more severe are the symptoms of withdrawal syndrome), the biological half-life of the drug (the lower the half-life, the higher is the risk of causing withdrawal syndrome).

Benzodiazepines have a specific antagonist on BZ receptors - flumazenil. Its use can quickly counter the effect of benzodiazepines (but not barbiturates nor alcohol).

Benzodiazepines are synergists of all drugs that cause the depression of the CNS. They have adverse effects on memory and other cognitive functions (concentration and judgment, learning capability), which may manifest as amnesia, the disruption of memory continuity, especially among elderly people. They are not well suited for people that require high alertness and fast reactions (driving, operating heavy machinery). They increase the effects of alcohol and inversely, the alcohol inhibits the metabolism of long-duration benzodiazepines (e.g. the inhibition lasts for 10 hours after taking the last dose of diazepine).

Hypnotics, including alcohol, are affected by cross-tolerance. This explains why it is impossible to cause sufficient effect in patients with a history of alcohol or hypnotics abuse.

Drugs of both categories of anxiolytics quickly pass through the placental barrier. The fetus doesn't metabolize them as quickly as an adult. The teratogenic effect hasn't been proved, but some sources describe the increased incidence of cleft lip and palate and low birth weight and length in feti of mothers that used these drugs in the 1st trimester of pregnancy. If they are used in the 3rd trimester, they may lead to toxic manifestations in the newborn (lethargy, hypotony, hypothermia - so-called "floppy infant") or withdrawal symptoms (tremor, tachypnoea, spasticity, etc.). It is therefore recommended to stop using anxiolytics one month before the childbirth. Benzodiazepine anxiolytics pass to the mother's milk and may lead to sedation of the infant. Because of this, mothers using anxiolytics with medium to long half-life shouldn't breastfeed.

  1. Benzodiazepiny se silným účinkem hypnotickým a slabým anxiolytickým
    • Působí rovněž slabě myorelaxačně. Jejich účinek je tedy nespecifický.
    1. Krátce působící (do 6 hod po poslední dávce),
      • Midazolam – působí rovněž do 6 hod po poslední dávce. Používá se v premedikaci před krátkodobými chirurgickými nebo interními výkony – gastroskopie, kolonoskopie, stomatochirurgie.
    2. Středně dlouho působící (8–10 hod),
      • Flunitrazepam.
    3. Dlouhodobě působící,
      • Nitrazepam, flurazepam – vyznačují se reziduálními ranními účinky (ospalost) a možností kumulace.
  2. Benzodiazepiny se silným účinkem anxiolytickým a slabším hypnotickým,
    • viz anxiolytika výše.

Sedatives

Sedatives are substances that cause sedation, a decrease of psychic and motoric activity, drowsiness, and fatigue. They are used to sedate patients treated with hypertension, vegetative dystonia (increased perspiration, palpitation, hot flashes), and others. Their toxicity is low.

Antiepileptics (anticonvulsives)

BZD belongs to 2nd generation antiepileptics. Others in this category are clonazepam, diazepam, lorazepam (status epilepticus, absence seizure)

  • status epilepticus requires i. v. diazepam, lorazepam, midazolam
  • mechanism of the effect of BZD antiepileptics: potentiation of GABA'S effect (also valproate, barbiturate, vigabatrin, tiagabine)

Muscle relaxants

Benzodiazepines are acting as central muscle relaxants.

Muscle relaxants:

  • Affect spasticity (myotonolytics)
  • Suppress mono- and polysynaptic reflexes in the brain and spinal cord
  • Takes effect in the GABA area, decreasing the generation of action potentials in the neurons


Benzodiazepines:

  • Stimulate GABA's effect and open Cl channels
  • Relax the muscles (muscle relaxant) and psyche (anxiolytic)

Another example of central muscle relaxants is baclofen.

Links

Related atricles

References

Used literature